Colorectal Cancer Market: Size, Growth, Industry Share, Forecast And Analysis Report By 2027
The global colorectal cancer market
is expected to reach US$ 22,953.8 Mn in 2027 from US$ 16,339.9 Mn in 2018.The
market is anticipated to grow with a CAGR of 4.0% from 2019-2027.
Driving factors of the colorectal cancer are increasing prevalence
of colorectal cancer, new product launches and benefits offered by generic
drugs. Moreover, growing pharmaceutical industry in emerging economies is
likely to have a positive impact on the growth of the market in the coming
years.
Generic drugs are alternatives of branded drugs. The pharmacological effects of generic drugs are similar to their branded counterparts. Generic drugs are cost-effective as the manufacturers does not invest in the development and marketing a new drug. After the expiry of a drug patent, other manufacturers apply for FDA approval of a generic intended for its manufacturing and selling.
Get
Sample PDF Of Colorectal Cancer Market @
Generic drugs are important in oncology due to the fact that some
of the anticancer drugs are only offered as generics. Patients are likely seen
to abandon branded prescriptions which are majorly associated with their higher
co-pays. Among developing countries such as India, where the paying capacity is
relatively low, generic drugs for cancer treatment acts as a boon for both the
manufacturers as well as patients due to its affordability and efficacy. For
instance, in June 2016, Hetero launched a Biosimilar 'Bevacizumab' for the
treatment of metastatic colorectal cancer under the brand name “Cizumab”. One
of the most striking benefit of using generic drugs is the cost that is up to
85% less than that of the branded drugs.
Ask
For Discount @
The global colorectal cancer market, based on the modality, is segmented into diagnosis type, therapy type, and imaging type. In 2018, the diagnosis type segment held the largest market share of the colorectal cancer market. Based on the end user, market is segmented into hospitals, diagnostic and research laboratories. Hospitals segment is expected to dominate the end user segment during the forecast period.
Some of the important primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization (WHO), American Society of Clinical Oncology, American Type Culture Collection, Centers for Disease Control and Prevention, National Colorectal Cancer Roundtable and others.
Reason to Buy
• Save
and reduce time carrying out entry-level research by identifying the growth,
size, leading players and segments in the colorectal cancer market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global colorectal cancer market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global colorectal cancer market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
About
Us :
Intelligence Market Research &
Consulting, LLP (IMRC) is a global provider of research reports, business
intelligence & consulting services. We know and understand the importance
of market research data for your institution. Therefore, we have teamed up with
the leading research institutes and strategy specialists to bring to you the
latest, niche and most relevant statistical research.
At IMRC, we have one of the most
exhaustive, highly reliable database of market research reports sourced from
publishers and authors after a thorough quality check and screening of the
market study and credentials. We have a team of key market experts who evaluate
the market size, growth prospects, end-use, applications, value & supply
chain and top vendors in the industry to help the clients to take most accurate
and logical business decisions without any vague assumptions.
Contact
Us:
699, Butler St. Suite 1007
Saugatuck, MI - 49453, United States.
Email
Id: sales@intelligencemarketresearch.com
Phone : +1 209
691 5657
Comments
Post a Comment